4DMedical Ltd ASX: 4DX Share Price & Review

4DX Overview

4DX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Strong

Earnings

Very Weak

Growth

Earnings

Weak

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Weak

About 4DX

Website

4DMedical Ltd

Telephone

61.3.9545.5940

Address

700 Swanston Street Level 7 Carlton, Victoria (VIC) 3053

Description

4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. It develops pipeline products that may assist physicians to more effectively diagnose and manage patients with lung disease, which includes XV ventilation analysis, ventilation perfusion, contrast free pulmonary angiography, small animal ventilator, and preclinical scanner. The company was founded by Andreas Fouras in December 2012 and is headquartered in Carlton, Australia.

4DX Price Chart

Key Stats

Market Cap

AU$135.17M

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.22 - 0.71

Trade Value (12mth)

AU$93,695.00

1 week

1 month

18%

YTD

-38.54%

1 year

-46.85%

All time high

2.98

Key Fundamentals

EPS 3 yr Growth

18.60%

EBITDA Margin

Operating Cashflow

-$31m

Free Cash Flow Return

-40.90%

ROIC

-47.70%

Interest Coverage

-167.30

Quick Ratio

1.70

Other Data

Shares on Issue (Fully Dilluted)

413m

HALO Sector

Technology

Next Company Report Date

28-Aug-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.01

4DX Announcements

Latest Announcements

Date	Announcements
05 May 25	4DMedical wins commercial contract with Intermountain Health × 4DMedical wins commercial contract with Intermountain Health
02 May 25	Application for quotation of securities - 4DX × Application for quotation of securities - 4DX
02 May 25	Top 20 Option Holders & Distribution Schedule × Top 20 Option Holders & Distribution Schedule
01 May 25	Results of EGM × Results of EGM
29 April 25	Quarterly Activity Report and Appendix 4C for Q3 FY2025 × Quarterly Activity Report and Appendix 4C for Q3 FY2025
24 April 25	Application for quotation of securities - 4DX × Application for quotation of securities - 4DX
24 April 25	Notification regarding unquoted securities - 4DX × Notification regarding unquoted securities - 4DX
16 April 25	Supplementary Prospectus × Supplementary Prospectus
16 April 25	Revised Target Market Determination × Revised Target Market Determination
15 April 25	4DMedical converts Integral Diagnostics pilot into contract × 4DMedical converts Integral Diagnostics pilot into contract
15 April 25	Change of registry address × Change of registry address
11 April 25	Notification of cessation of securities - 4DX × Notification of cessation of securities - 4DX
10 April 25	4DMedical wins industry partners and discussed in Congress × 4DMedical wins industry partners and discussed in Congress
01 April 25	Letter to Shareholders, Notice of EGM & Proxy Form × Letter to Shareholders, Notice of EGM & Proxy Form
26 March 25	Cost reduction program delivers $6.5m in annualised savings × Cost reduction program delivers $6.5m in annualised savings
25 March 25	4DMedical completes oversubscribed $8.4m SPP × 4DMedical completes oversubscribed $8.4m SPP
25 March 25	Application for quotation of securities - 4DX × Application for quotation of securities - 4DX
25 March 25	Prospectus × Prospectus
25 March 25	Target Market Determination × Target Market Determination
11 March 25	3-year contract extension secured with the Cleveland Clinic × 3-year contract extension secured with the Cleveland Clinic
03 March 25	Change of Director's Interest Notice × Change of Director's Interest Notice
03 March 25	Change of Director's Interest Notice × Change of Director's Interest Notice
03 March 25	Notification of cessation of securities - 4DX × Notification of cessation of securities - 4DX
28 February 25	Appendix 4D and Half-Year Report × Appendix 4D and Half-Year Report
28 February 25	1H FY2025 Half-year results × 1H FY2025 Half-year results

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Falling Divs over next 2

Values and Recommendations

Key Stats

Consensus Score

Recommendation

EPS 1 month Change

Quality Yield

Falling Divs over next 2

Halo Consensus Score

PEG Ratio

Consensus EPS Revisions

Short selling

Key Stats

Percent of Issue

0.01%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

-0.10%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

4DX Shortsell

Frequently Asked Questions

What is the current share price of 4DMedical Ltd (4DX:ASX)?

The current share price of 4DMedical Ltd (4DX:ASX) is AU$0.29.

What is the 52-week high share price for 4DMedical Ltd (4DX:ASX)?

The 52-week high share price for 4DMedical Ltd (4DX:ASX) is AU$0.71.

What is the 52-week low share price for 4DMedical Ltd (4DX:ASX)?

The 52-week low share price for 4DMedical Ltd (4DX:ASX)? is AU$0.22.

What is the dividend yield for 4DMedical Ltd (4DX:ASX)?

4DMedical Ltd (4DX:ASX) does not pay a dividend.

What was 4DMedical Ltd (4DX:ASX) last dividend payment?

4DMedical Ltd (4DX:ASX) does not pay a dividend.

What is the franking level for 4DMedical Ltd (4DX:ASX)?

4DMedical Ltd (4DX:ASX) has a franking level of 0.0%.

In which sector is 4DMedical Ltd (4DX:ASX) classified?

4DMedical Ltd (4DX:ASX) is classified in the Technology.

The current P/E ratio for 4DMedical Ltd (4DX:ASX) is .

Company

Important

Get the latest insights and hot tips delivered right to your inbox

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.

4DX · ASX

4DMedical Ltd (ASX:4DX)

AU$0.29

4DX Overview

4DX Health Scores

About 4DX

4DX Price Chart

Key Stats

AU$135.17M

N/A

N/A

Dividends Overview

N/A

N/A

N/A

Market Data

Key Fundamentals

Other Data

4DX Announcements

Latest Announcements

4DMedical wins commercial contract with Intermountain Health

Application for quotation of securities - 4DX

Top 20 Option Holders & Distribution Schedule

Results of EGM

Quarterly Activity Report and Appendix 4C for Q3 FY2025

Application for quotation of securities - 4DX

Notification regarding unquoted securities - 4DX

Supplementary Prospectus

Revised Target Market Determination

4DMedical converts Integral Diagnostics pilot into contract

Change of registry address

Notification of cessation of securities - 4DX

4DMedical wins industry partners and discussed in Congress

Letter to Shareholders, Notice of EGM & Proxy Form

Cost reduction program delivers $6.5m in annualised savings

4DMedical completes oversubscribed $8.4m SPP

Application for quotation of securities - 4DX

Prospectus

Target Market Determination

3-year contract extension secured with the Cleveland Clinic

Change of Director's Interest Notice

Change of Director's Interest Notice

Notification of cessation of securities - 4DX

Appendix 4D and Half-Year Report

1H FY2025 Half-year results

Dividends

Key Stats

N/A

N/A

N/A

N/A

Values and Recommendations

Key Stats

Halo Consensus Score

PEG Ratio

Consensus EPS Revisions

Short selling

Key Stats

0.01%

0

N/A

N/A

N/A

-0.10%

Discover Short-sellingOpportunities

4DX Shortsell

Related Companies

Frequently Asked Questions

Company

Company

Important

Discover
Short-selling
Opportunities